Compositions comprising lipoxygenase inhibitors and cyclodextrin

Details for Australian Patent Application No. 2006315169 (hide)

Owner Baxter Healthcare S.A. Baxter International, Inc.

Inventors Gupta, Pramod; Kipp, James E.

Agent Peter Maxwell & Associates

Pub. Number AU-A-2006315169

PCT Pub. Number WO2007/059507

Priority 60/736,980 15.11.05 US

Filing date 15 November 2006

Wipo publication date 24 May 2007

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 31/38 (2006.01) - having sulfur as a ring hetero atom

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

Event Publications

15 May 2008 PCT application entered the National Phase

  PCT publication WO2007/059507 Priority application(s): WO2007/059507

4 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006315175-Compositions and methods for modulating hemostasis

2006315167-Light line generating assembly